Sara M. Tolaney, Evandro de Azambuja, Kevin Kalinsky, Sherene Loi, Sung-Bae Kim, Clinton Yam, Bernardo Leon Rapoport, Seock-Ah Im, Barbara Pistilli, Wassim Mchayleh, David W. Cescon, Junichiro Watanabe, Alejandro Lara, Ruffo Freitas-Junior, Javier Salvador Bofill, Maryam Afshari, Dianna Gary, Lu Wang, Catherine Lai, Peter Schmid. "Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the randomized phase 3 ASCENT-04/KEYNOTE-D19 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.17_suppl.lba109